Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

Event features discussions about health care industry trends, best practices and innovations

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

A look at the specialty landscape and how Prime delivers value to employers

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

Managed Markets Insight & Technology (MMIT)

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.